Search for: "Astrazeneca"
Results 901 - 920
of 1,246
Sorted by Relevance
|
Sort by Date
25 Aug 2015, 7:10 am
Other inhibitors in this class include Farxiga and Xigduo by AstraZeneca, Jardiance by Lilly, and Glyxambi by Boehringer Ingelheim. [read post]
10 Nov 2008, 2:07 pm
AstraZeneca Pharmaceuticals LP, the court held that the complexity of having to prove the extent to which there actually was prescribing physician reliance - or none at all - or something in between - required dismissal of a third-party payer suit under Holmes v. [read post]
22 Apr 2016, 4:37 pm
PPIs have generated billions of dollars in sales for their manufacturers, and three of the most common brand names that are prescribed on the market include: Prilosec Nexium Prevacid Prilosec and Nexium are manufactured by AstraZeneca, one of the true titans of the pharmaceutical industry. [read post]
21 Sep 2010, 7:47 pm
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
28 Aug 2009, 8:11 am
Hewlett-Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. [read post]
1 Feb 2012, 6:12 am
Astrazeneca U.K, Ltd., 628 F.3d 643, 651 (4th Cir. 2010) (applying English law / federal common law to enforce forum selection clause via dismissal). [read post]
18 Nov 2021, 11:51 am
In Canada, the National Advisory Committee on Immunization has recently made interim recommendations that the following groups receive a booster shot: adults 70 years and older adults living in long term care or other congregate settings that provide care for seniors anyone who received two doses of the AstraZeneca/COVISHIELD vaccine or one dose of the Johnson & Johnson vaccine adults in or from First Nations, Inuit and Métis communities adults who are front-line health-care… [read post]
2 Feb 2009, 11:23 am
The opinion appeared to give AstraZeneca Pharmaceuticals a boost (although there are a thousand variables that are involved in the 1% rise in the stock price - the Seroquel lawsuits are a small piece of the large mosaic that is a major pharmaceutical company) and depress not only Seroquel litigants and their lawyers, but also plaintiffs' lawyers in drug and medical device litigation, who have had a tough year. [read post]
18 Jun 2012, 8:08 am
Lilly paid more than $1.7 billion, reports Bloomberg, to settle federal and state investigation over its atypical antipsychotic Zyprexa, while AstraZeneca has paid almost $590 million. [read post]
26 May 2007, 11:26 pm
.# AstraZeneca's Seroquel for acute mania associated with bipolar disorder is being challenged by Teva Pharmaceutical Indus tries. [read post]
17 Jul 2010, 7:24 am
., AstraZeneca Pharms. [read post]
23 Aug 2012, 7:00 am
The big loser in Q2 was AstraZeneca's Seroquel, which dropped 95 places to #100 on the list of the top 100, coming in at $159,858,000 in sales for the quarter. [read post]
28 Mar 2009, 2:26 am
Examples Of Qui Tam Related Recoveries: $355,000,000 AstraZeneca $334,000,000 Amerigroup $325,000,000 HealthSouth $257,000,000 Bayer $155,000,000 Medco Health $49,000,000 Pfizer $26,000,000 Key West Pharmacy Qui Tam Web Resources: FALSE CLAIMS ACT CASES: GOVERNMENT INTERVENTION IN QUI TAM (WHISTLEBLOWER) SUITS Medicare Fraud HHS Takes Further Steps to Protect Medicare From Fraudulent Durable Medical Equipment Suppliers [read post]
28 Mar 2009, 2:26 am
Examples Of Qui Tam Related Recoveries: $355,000,000 AstraZeneca $334,000,000 Amerigroup $325,000,000 HealthSouth $257,000,000 Bayer $155,000,000 Medco Health $49,000,000 Pfizer $26,000,000 Key West Pharmacy Qui Tam Web Resources: FALSE CLAIMS ACT CASES: GOVERNMENT INTERVENTION IN QUI TAM (WHISTLEBLOWER) SUITS Medicare Fraud HHS Takes Further Steps to Protect Medicare From Fraudulent Durable Medical Equipment Suppliers [read post]
27 Nov 2006, 2:20 pm
AstraZeneca PLC and Novartis AG this year each committed to spending $100 million on research and development in China. [read post]
17 Sep 2024, 2:36 pm
The firm’s involvement in In Re: Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation also led to a landmark settlement, with over $1.075 billion in compensation for affected patients and a landmark $425 million settlement with AstraZeneca Pharmaceuticals in 2023 in the Proton-Pump Inhibitor Products Liability Litigation centralized before Judge Claire Cecchi in the District of New Jersey. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
2 Nov 2007, 11:00 pm
.'s stent patents, in a ruling that comes at the end of a five-year battle between the medical device makers (IPLaw 360), Wi-LAN, a Canadian licensing company has targeted 22 of the world's largest computer chip manufacturers, equipment vendors and electronics retailers for allegedly violating patents related to wireless computer connections: (Philip Brooks), (IP Law 360), (Patent Troll Tracker), (ZDNet), (Peter Zura),Dexcel Pharma Technologies Ltd. has reached a settlement with… [read post]
9 Nov 2008, 11:48 pm
Second, AstraZeneca, the manufacturer of Crestor, the largest selling cholesterol-reducing drug in the world, orchestrated the study and funded it in order to justify new reasons for prescribing it to people with normal cholesterol levels. [read post]
23 Nov 2007, 9:00 am
Astra's Data Exclusivity prevents a European generic launch, until at least 2010.: (Generic Pharmaceuticals & IP), Iressa (gefitinib) - Astrazeneca's Indian patent application rejected: (Generic Pharmaceuticals & IP), Ziagen (Abacavir Hemisulfate Salt) -GSK's application [872/CAL/98; corresponding to Orange Book listed US6294540] opposed by Indian Network for People living with HIV/ AIDS and then withdrawn by GSK: (Generic Pharmaceuticals & IP), Thai… [read post]
